openPR Logo
Press release

Immuno Oncology Assays Market Size and Growth Trajectory 2024-2031: Industry Insights and Predictions |Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc.

09-09-2024 09:26 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Immuno-Oncology Assays Market

Immuno-Oncology Assays Market

The latest market intelligence report published by CMI with the title "Global Immuno Oncology Assays Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Biotechnology industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.

The Research report on Immuno Oncology Assays Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps' Analysis, Market Attractiveness Analysis, BPS Analysis, Ecosystem Analysis.

Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: : - https://www.coherentmarketinsights.com/insight/request-sample/2632

*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.

***Key trends***

- Increased Focus on Combination Therapies: More than 60% of ongoing trials involve combo therapies to improve patient outcomes.

- Next-Gen Assay Technologies: Advanced multiplex assays and tissue imaging techniques are improving diagnostic accuracy.

- Surge in Biomarker Development: Over 300 biomarkers are in clinical trials to identify responder groups.

- Asia Pacific Growth Accelerates: China, Japan and India are emerging hubs for IO drug development and clinical trials.

- Diagnostic Adoption Rises: Uptake of companion diagnostics along with therapeutics is driving assay adoption.

Want to access more insights? The journey starts from requesting Sample: : - https://www.coherentmarketinsights.com/insight/request-sample/2632

*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR):

By Product: Consumables and Software
By Technology: Immunoassay, PCR, NGS, Fow Cytometry, and Others
By Indication: Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others
By Application: Clinical Diagnostics and Research and Development

• By Regions and Countries

o North America
o Europe
o Asia-Pacific
o South America
o Middle East & Africa

Following are the players analyzed in the report:

◘ Charles River Laboratories
◘ F. Hoffmann-La Roche Ltd
◘ llumina Inc.
◘ Agilent Technologies Inc.
◘ Thermo Fisher Scientific Inc.
◘ Merck KGaA
◘ Invivoscribe Inc.
◘ QIAGEN
◘ PerkinElmer Inc.
◘ Sartorius AG
◘ Bio-Rad Laboratories Inc.
◘ Bruker Spatial Biology Inc.
◘ Nexelis
◘ Reaction Biology
◘ Crown Bioscience
◘ HTG Molecular Diagnostics Inc.
◘ Axion BioSystems Inc
◘ BioTherapeutics LLC

Get access to the latest Edition of this Market Study (comprising 150+ pages) and Get Up to 25% Discount: : https://www.coherentmarketinsights.com/insight/buy-now/2632

Deep-dive Analysis:

The Report provides deep-dive qualitative and quantitative analysis on Immuno Oncology Assays Market for all the regions and countries covered below:

➢ North America (the United States, Canada, and Mexico)
➢ Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
➢ Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
➢ South America (Brazil, Argentina, and Rest of South America)
➢ Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
➢ Each Country is covered in detail, and report provides qualitative and quantitative analysis on Immuno Oncology Assays Market on each country.

The research provides answers to the following key questions:

1.What is the estimated growth rate of the market for the forecast period 2024-2031? What will be the market size during the estimated period?
2.What are the key driving forces responsible for shaping the fate of the Immuno Oncology Assays market during the forecast period?
3.Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Immuno Oncology Assays market?
4.What are the prominent market trends influencing the development of the Immuno Oncology Assays market across different regions?
5.What are the major threats and challenges likely to act as a barrier in the growth of the Immuno Oncology Assays market?
6.What are the major opportunities the market leaders can rely on to gain success and profitability?

Key insights provided by the report that could help you take critical strategic decisions?

• Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
• Reports provide opportunities and threats faced by suppliers in the Immuno Oncology Assays and tubes industry around the world.
• The report shows regions and sectors with the fastest growth potential.
• A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
• The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
• This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
• This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

Author of this marketing PR:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

☎ Contact Us:

Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immuno Oncology Assays Market Size and Growth Trajectory 2024-2031: Industry Insights and Predictions |Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc. here

News-ID: 3649134 • Views:

More Releases from Coherent Market Insights

Global Composite Adhesive Market Insights: Valued with Industry Insights, Share Analysis, Size and Growth Trajectory Report by Forecast 2024 - 2031 | Henkel AG & Co. KGaA, Master Bond Inc
Global Composite Adhesive Market Insights: Valued with Industry Insights, Share …
The global composite adhesive market size is valued at US$ 3.58 Billion in 2024 and is expected to grow at a CAGR of 6.6% during the forecast period. Composite adhesives are bonding agents used to join composite materials together. There are various types of composite adhesives available, depending on the substrate material and application. The latest market intelligence report published by CMI with the title " Global Composite Adhesive Market 2024,
Spray Foam Insulation Market Dynamics: Insights with Industry Insights, Share Analysis, Size and Growth Trajectory Report by Forecast 2024 - 2031 | BASF Corporation, Demilec, Johns Manville
Spray Foam Insulation Market Dynamics: Insights with Industry Insights, Share An …
Global spray foam insulation market is estimated to be valued at USD 2.97 Bn in 2024 and is expected to reach USD 4.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031. The latest market intelligence report published by CMI with the title "Global Spray Foam Insulation Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Bulk Chemicals industry. The report provides demand
Bowen Disease Treatment Market Dynamic Growth Factors, In-Depth Analysis And Outlook By Forecast To 2031 | Intas Laboratories Pvt Ltd, Cadila, Pharmaceuticals Ltd., VHB Life Sciences Limited
Bowen Disease Treatment Market Dynamic Growth Factors, In-Depth Analysis And Out …
Global Bowen Disease Treatment Market Growing Demand and Growth Opportunity 2024-2031: The Coherent Market Insights A new report research on the Bowen Disease Treatment Market from 2024 to 2031 provides accurate economic, global, and country-level predictions and analyses. It presents a comprehensive view of the competitive landscape, along with a detailed supply chain analysis to aid businesses in detecting significant industry practice changes. Additionally, the market report assesses the present state
Sugar Free Lifesavers Market Trends: Industry Insights, Share Analysis, Size and Growth Trajectory Report Estimated by 2031 | Perfetti Van Melle, The Hershey Company
Sugar Free Lifesavers Market Trends: Industry Insights, Share Analysis, Size and …
Global sugar free lifesavers market is estimated to be valued at USD 2.62 Bn in 2024 and is expected to reach USD 3.58 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031. The latest market intelligence report published by CMI with the title "Global Sugar Free Lifesavers Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Food and Beverages industry. The report provides

All 5 Releases


More Releases for Immuno

Organic Dispersion To Drive The Immuno-Oncology Market
The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients' immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several traditional methods used in the treatment of cancer such as chemotherapy, radiation therapy, and surgery, etc. carry the risk
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Next Gen Immuno-Oncology Congress - 4th Annual MarketsandMarkets
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction. Register as a Delegate at https://www.reportsnreports.com/events/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress/register o 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Con …
There’s just under 4 weeks until SMi’s Immuno-Oncology Conference commences in London on the 26th and 27th September (www.immuno-oncology-conference.com/openpr). The event aims to propagate thought-provoking discussions about the future of Immuno-Oncology between industry leaders, and update delegates on current key areas for development, advancements in therapy and revisions of regulations. The study of immuno-oncology has been ever-present in recent news, with biomarkers in melanoma having been recently identified by Dana-Farber Cancer Institute
Immuno-Oncology Conference, London – agenda released
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference (26 – 27 September 2018, London, UK) will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress. Agenda - Valuable time is spent to